Marialuisa Scarpone, MD

[Dr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦 @DrMarthaGulati]

#ESCCongress

[Marialuisa Scarpone, MD @M_Scarpone]

@perc_surgeon @ChristHospital So beatiful...leaving a team for something new and still love the old team. You are lucky! Best wish for the future ✌

[Marialuisa Scarpone, MD @M_Scarpone]

@hect2701 @CiticMexico @SOCiME_ @PCRonline @TCTMD @CRT_meeting @carlos__campos Thank you...

[Marialuisa Scarpone, MD @M_Scarpone]

Have a look at this #ESCAbstract on the #ESCCongress Research Gateway #COVID https://t.co/7GjhYGN4jq via @escardio

[Marialuisa Scarpone, MD @M_Scarpone]

Have a look at this #ESCAbstract on the #ESCCongress Research Gateway #cardionco #cardioncology
https://t.co/PhLrOTamjZ via @escardio

[Marialuisa Scarpone, MD @M_Scarpone]

Risk factors, revascularization therapies and cardiovascular mortality in countries with middle and low public health expenditure.
@Cardio_ISACS @EdinaCenko @RBugiardini @maria_bergami @OliviaManfrini #ESCCongress #ESC2020 #SoMe https://t.co/8I1zncLDMk

[Edina Cenko @EdinaCenko]

Great work @423db50c121a429 & @Cardio_ISACS investigators! Check out #ESCCongress variations in #riskfactors #reperfusion therapies & #CVD mortality of #ACS in countries w/middle & low pubblic health expenditure @maria_bergami @RBugiardini @EdinaCenko @OliviaManfrini @escardio

[Edina Cenko @EdinaCenko]

This year #ESCCongress is digital & free! Full programme released

[Dr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦 @DrMarthaGulati]

Found the paper now released too! Congratulation @RBugiardini et al! I guess the goal is to treat BP adequately & other CVD risk factors to prevent #ACS but maybe BB need to be used⬇️. I don't like them in 💃 much TBH already. @cardioPCImom @mirvatalasnag
https://t.co/4qk2VN6pJu

[Hypertension @HyperAHA]

Beta-blocker therapy in hypertension may be an acute precipitant of heart failure among women with incident coronary heart disease. @RBugiardini @GoranEBC @zoranav1 @OliviaManfrini @MihaelaVDS @cpgale3 @lbadimon @EdinaCenko @Cardio_ISACS
https://t.co/a4r6CiKbD9

[Cardiology Today @CardiologyToday]

Beta-blocker use may precipitate HF in women with new-onset CHD but not in men @RBugiardini @HyperAHA #HeartFailure #CardioTwitter @American_Heart https://t.co/pPXupHNjZG

[Edina Cenko @EdinaCenko]

β-blockers use may be a precipitant of heart failure in #women with new-onset CHD, past hx of hypertension & w/out prior CVD
@RBugiardini @OliviaManfrini @cpgale3 @MihaelaVDS @GoranEBC @zoranav1 @lbadimon @HyperAHA @AHA_Research @AHAScience

[Università di Bologna @Unibo]

Un nuovo studio ha esaminato in che modo il sesso dei pazienti che, per la cura dell’ipertensione, fanno uso di questi farmaci può influire in caso di infarto del miocardio, mostrando un rischio più elevato tra le donne

https://t.co/Il7LEFSqJs

#Unibo

[Raffaele Bugiardini @RBugiardini]

Higher Risk of HF After ACS for Women Previously on Beta-blockers https://t.co/DVObDtqYU9 #betablockers #cardiotwitter #hypertension #women #sexdifferences #coronaryheartdisease

[Edina Cenko @EdinaCenko]

Prior Beta-blockers taken for #hypertension may predispose #women to worse outcomes, compared with men, when they later present with #ACS
@RBugiardini @HyperAHA #cardiotwitter #CardioEd
https://t.co/OhvwJGA7bu

[Raffaele Bugiardini @RBugiardini]

Sex equality in quality of care is not just good for women- it's good for the whole society. The use of ß-blockers for treatment of #hypertension in #women with no prior history of #cardiovasculardisease is an unnecessary risk https://t.co/w7wWfgKjU3 via @medscape

[Raffaele Bugiardini @RBugiardini]

Past research on the effects of β-blockers included mostly male patients. The problem seems to me not that there are #sexdifferences in #coronarydisease but rather how we may value these differences @cpgale3 @GoranEBC @bnallamo @DrMarthaGulati @lbadimon @EdinaCenko @HyperAHA

[Sasa P. @sasap0909]

@Cardio_ISACS going with modern analytical methods and utilizes machine learning. @EdinaCenko @RBugiardini @bookwormscats @423db50c121a429 #ESCcongress2019 #WCC2019 #cardiotwitter

[Edina Cenko @EdinaCenko]

Machine Learning in NSTE-ACS patients with diabetes & early PCI.
Machine Learning do not prespecify a set of factors, therefore mitigare bias
@RBugiardini @OliviaManfrini @EdinaCenko @423db50c121a429
@bookwormscats @Cardio_ISACS #cardiotwitter #ESCCongress

[Edina Cenko @EdinaCenko]

Congratulations @423db50c121a429 & all the @Cardio_ISACS team for presenting results on CV effects of smoking in #women #cardiotwitter #ESCCongress @RBugiardini @EdinaCenko @bookwormscats @OliviaManfrini @sasap0909